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Abstract 
Review on duplication of 1q in acute lymphoblastic 
leukemia, with data on clinics, and the genes 
involved. 
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Top:  G-banded hyperdiploid karyotype with duplication 1q from an ALL case.  Bottom:  G-banded 
hyperdiploid karyotype fom ALL patient showing an unbalanced der(1;6)(q10;p10) resulting in gain/trisomy 1q.
 
 
dup(1q) in ALL  Fluorescence in situ hybridization with Vysis LSI 1p36/LSI 1q25 dual-color probe (Abbott 
molecular, US) showing 2 normal copies of 1q25 on normal (A) and 3 copies of green signal on metaphase with 
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1q duplication (B) and on metaphase with inverted 1q duplication (C). Partial karyotypes and metaphase with C-
band showing the inverted duplication of 1q (D) Courtesy Adriana Zamecnikova. 
 
Clinics and pathology 
Disease 
Acute Lymphoblastic Leukemia (ALL) 
Cytogenetics 
Duplication or gain of 1q may result from a partial 
interstitial duplication of 1q or more often from an 
unbalanced translocation (Figure 1, 2). Although 
dup(1q) is rarely seen as a sole abnormality, it is 
mostly found in association with well-known 
primary cytogenetic abnormalities. In high 
hyperdiploid ALL, duplication of 1q is the most 
frequent structural aberration found in 
approximately 15% cases (Figure 1). Gain of 1q is 
also associated with t(1;19) translocation; 75% of 
those cases have an unbalanced translocation leading 
to gain/trisomy 1q. Additionally, partial trisomy of 
1q is found in almost 25% of Burkitt 
lymphoma/leukemia (BL) cases in particular the 
endemic type. Therefore, duplication/gain of 1q in 
ALL is an apparently a secondary event.  
 
The size of the duplicated region of 1q is variable but 
mostly reported form 1q21 -> qter. Using array 
CGH, Davidsson et al studied ten cases with 
duplicated 1q; six cases of B-cell precursor pediatric 
high hyperdiploid ALL and four cases of BL.  The 
proximal breakpoints in all cases were near the 
centromere, mostly clustering within a 1.4 Mb 
segment at 1q12-21.1. There was no evidence 
hypomethylation of sat II DNA in ALLs with or 
without 1q gains indicating that aberrant methylation 
was not involved in the formation of dup(1q), as 
previously suggested for other neoplasms with 1q 
rearrangements. However, the 1q distal breakpoints 
were heterogeneous, being more distal in the ALLs 
than in the BLs. Thus, the minimally gained segment 
was larger in the ALLs (57.4 Mb) than in the BLs 
(35 Mb), corresponding to dup(1)(q22q32.3) and 
dup(1)(q12q25.2), respectively. 
Prognosis 
The presence of dup(1q) has no effect on the 
outcome of ALL patients with high hyperdiploidy 
(Paulsson et al, 2013). It is unclear yet whether the 
presence of balanced or unbalanced 
t(1;19)(q23;p13.3) in ALLs has an effect on the 
prognosis. 
Genes involved and 
proteins 
Note 
The molecular characterization of dup(1q) in ALL is 
not well-defined and very limited data is available. 
However, the unbalanced nature of dup(1q) suggests 
that gene dosage effect is likely contribute to the 
neoplastic process. Nevertheless, gene expression 
profile revealed that five genes, DAP3, B4GALT3, 
UCK2, RGS16 and TMEM183A were significantly 
up-regulated in high hyperdiploid ALL carrying 
dup(1q) compared to those without  dup(1q). DAP3 
and UCK2 genes were among the highly expressed 
in BL with gain of 1q (Davidsson et al 2007). 
DAP3 (death associated protein 3) 
Location 
1q22 
Note 
Alternative symbol MRPS29 (mitochondrial 
ribosomal protein S29). 
Protein 
DAP3 gene is transcribed into a 1.7-kb mRNA and 
translates into a 46 kDa protein located in the lower 
area of the small mitoribosomal subunit. This protein 
contains a P-loop motif that binds GTP and a highly 
conserved 17-residue targeting sequence responsible 
for its localization to the mitochondria.  Many of the 
phosphorylation sites on this protein are highly 
conserved and clustered around GTP-binding motifs. 
DAP3 forms an important portion of the a 28S 
subunit protein of the mitochondrial ribosome and 
plays key roles in translation, cellular respiration, 
and apoptosis. The protein is normally reserved 
inactive as phosphoprotein. When activated, it co-
localizes with FADD and participates in the 
formation of the death inducing signaling complex 
(DISC). Recent studies suggests that DAP3 is 
strongly associated with the Fas receptor related 
DISC. It is presumed that DAP3 may have tumor 
suppressant role predicated by its function as a pro-
apoptotic molecule. Counterintuitively, DAP3 has a 
pro-survival role in mitochondrial function. The 
current literature places DAP3 at the link of several 
highly significant and occasionally antagonistic 
pathways (Kissil JL et al 1995, 1998).  
 
There is limited literature with regards to DAP3 role 
in cancer. Studies have demonstrated low  DAP3 
expression in various tumors such as B-cell 
lymphoma, lung cancer, head and neck cancer , 
breast cancer, gastric cancer, and colorectal 
carcinoma, possibly due to hypermethylation of the 
gene's promoter (Wazir U et al, 2015). In breast 
cancer it has been demonstrated that this gene may 
have a tumor suppressor function through promoting 
apoptosis and could act as a useful prognostic 
indicator in breast cancer (Wazir U et al, 2012). 
Moreover, DAP3 expression has been positively 
correlated with improved cancer prognosis, 
indicating that the protein combats cancer 
progression through its proapoptotic function. As a 
result, DAP3 could serve as a potential biomarker to 
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monitor the effectiveness of therapeutic treatments 
(Wazir et al, 2015). However, Mariani et al. found 
an upregulated expression of DAP3 in glioblastoma 
multiforme and in glioma cell lines with induced 
migratory phenotype. These observations can be 
explained by the fact that P-loop mutant DAP3 is less 
effective in inducing apoptosis, and the COOH-
terminal deleted protein (230 amino acids) acts in a 
dominant negative fashion, protecting cells from 
induced apoptosis (Mariani et al, 2001). 
Furthermore, such findings could reflect a different 
balance between the mitochondrial maintenance and 
the pro-apoptotic functions of the DAP3 levels in 
glioma. 
B4GALT3 (beta-1,4-
galactosyltransferase 3) 
Location 
1q23.3 
Protein 
B4GALT3 gene encodes an enzyme belongs to the 
family of B4GALTs, which catalyzes the 
biosynthesis of poly-N-acetyllactosamines. 
B4GALTs transfer galactose from uridine 
diphosphate galactose to N-acetylglucosamine 
(GlcNAc)-terminated oligosaccharides to form N-
acetyllactosamine. The B4GALT family consists of 
seven members with different tissue distributions, 
acceptor preferences and enzyme activities. Among 
its related pathways are transport to the Golgi and 
subsequent modification and metabolism. In 
colorectal carcinoma (CRC), the expression of 
B4GALT3 is negatively correlated with poorly 
differentiated histology, advanced stages and 
metastasis. It has shown that B4GALT3 may 
function as a metastasis suppressor in CRC through 
modulating β1 integrin glycosylation and activation 
(Chen et al 2014). 
UCK2 (uridine-cytidine kinase 2) 
Location 
1q24.1 
DNA/RNA 
UCK2 gene contains 7 exons and spans over 19 kb 
Protein 
It encodes a 261 amino-acid protein with a predicted 
molecular mass of 29 kDa. It is an enzyme, catalyzes 
the phosphorylation of uridine and cytidine to 
uridine monophosphate (UMP) and cytidine 
monophosphate (CMP), respectively. UCK2 has 
only been detected in human placental tissue and 
overexpressed in various tumor cells, including 
neuroblastoma. Recent studies suggest that UCK2 
could be used as a selective target for chemotherapy 
delivery in neuroblastoma cells expressing this 
specific isoform of UCK while sparing normal 
tissues (van Kuilenburg and Meinsma 2016). 
RGS16 (regulator of G protein 
signaling 16) 
Location 
1q25.3 
Protein 
This gene encodes protein belongs to the 'regulator 
of G protein signaling' family. It inhibits signal 
transduction by increasing the GTPase activity of G 
protein alpha subunits. Also it may play a role in 
regulating the kinetics of signaling in the 
phototransduction cascade. The RGS family, 
comprising 22 homologues of proteins, plays a role 
in cellular proliferation, differentiation, membrane 
trafficking, and embryonic development through the 
involvement of the mitogen-activated protein kinase 
signalling pathway. The activity and specificity of 
Rgs16 protein are regulated through 
phosphorylation, in which several oncogenes are 
involved, by modulating the phosphorylation on a 
tyrosine residue in the RGS box. Previous studies 
showed that RGS16 is overexpressed in high 
hyperdiploid ALL and several other cancers such as 
CRC. Patients with RGS16 high-expression had a 
poorer overall survival rate than patients with low-
expression suggesting that RGS16 is useful as a 
predictive marker for patient prognosis of CRC 
(Miyoshi et al 2009). 
TMEM183A (transmembrane protein 
183A) 
Location 
1q32.1 
Note 
Also known C1orf37 
DNA/RNA 
The TMEM183A is the parental gene of 
TMEM138B, which is a young gene derived through 
retroposition after the divergence of human and 
chimpanzee. There are only 6 nucleotide changes in 
the coding region between TMEM183A and 
TMEM183B genes (Yu et al 2006). 
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